The global doxorubicin market is witnessing steady growth, driven by rising cancer prevalence and increasing demand for effective chemotherapy drugs. The market was valued at USD 1,285.8 million in 2024 and is projected to reach USD 1,354.7 million in 2025, further expanding to USD 2,056.3 million by 2032, exhibiting a CAGR of 6.14% during the forecast period (2025–2032). The growth is...
Doxorubicin Market Experiences Robust Expansion Driven by Rising Cancer Cases; Key Therapeutic Applications and Growth Drivers Analyzed
The global oncology landscape is witnessing unprecedented demand for effective chemotherapy agents, and doxorubicin—a cornerstone anthracycline antibiotic—remains a linchpin in cancer treatment. With the World Health Organization (WHO) estimating...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek